Hypertension professionals from Asia have been meeting together for the last decade to discuss how to improve the management of hypertension. Based on these education and research activities, the Hypertension, brain, cardiovascular and renal Outcome Prevention and Evidence in Asia (HOPE Asia) Network was officially established in June 2018 and includes experts from 12 countries/regions across Asia.
| INTRODUC TI ON
The last decade has seen multiple face-to-face meetings between hypertension professionals from Asia. The consolidation of these activities resulted in the official establishment of the Hypertension, This article provides an overview of publications and recommendations in three key areas for hypertension in the region: Asian characteristics, home blood pressure monitoring (HBPM), and ambulatory blood pressure monitoring (ABPM) ( Table 1) . [1] [2] [3] [4] [5] 
| CON S EN SUS ON THE A S IAN CHAR AC TERIS TIC S OF HYPERTENS ION
The first key publication focused on taking Asia-specific characteristics into account to optimize the management of hypertension in the region. 1 Key findings are summarized in Table 2 .
Important features of hypertension in Asia include the high prevalence of stroke (especially hemorrhagic stroke) and nonischemic heart failure as complications of hypertension, a strong association between increasing blood pressure (BP) and rates of cardiovascular disease, and high salt sensitivity. 1, 6, 7 Use of out-of-office BP measurement is recommended, and specific information on ABPM and HBPM is provided by separate consensus documents (see below). [2] [3] [4] [5] Morning hypertension is a particularly important target for the management of hypertension in Asia. 1, 8 Although not yet completely understood, Japanese patients have been shown to have a much greater morning surge in BP and higher morning BP than those from Europe. 9 Potential mechanisms for these differences include Abbreviations: ABPM, ambulatory blood pressure monitoring; HBPM, home blood pressure monitoring. intake. 10, 11 Alternatively, suboptimal treatment of hypertension, including inadequate drug dosing, and/or under-usage of long-acting antihypertensive agents or combination therapies could be responsible for uncontrolled morning hypertension in Asia. 12 A comprehensive consensus statement on managing morning hypertension in Asia is available to guide clinical practice. 13 Other important factors in hypertension management in Asia include the aging population demographic, vascular aging, and comorbid type 2 diabetes mellitus, chronic kidney disease (CKD) or atrial fibrillation (AF). The importance of controlling BP to target in the elderly is highlighted by data showing that the rate of cardiovascular events in older adults with hypertension is two to three times higher than that in younger patients with the same BP levels. 14 Vascular aging is characterized by increased arterial stiffness and wave reflection, and is an important risk factor for hypertension, especially in older individuals. 15 It is expected to become the dominant phenotype of hypertension, particularly in Asia. 1
Asia-specific risk factors for vascular aging include increased central aortic pulse pressure due to the relatively larger diameter and thinner media at the proximal aorta that modulates the interaction between ventricular ejection and arterial load, higher central pulse pressure, and greater wall stress at the proximal aorta. 1, 16, 17 A target systolic blood pressure (SBP) of 130 mm Hg has been suggested as appropriate in Asian patients with hypertension and comorbid type 2 diabetes mellitus, CKD or AF. 1, 18 Strict control of BP is important in these patients due the increased risk attributable to the presence of the comorbidity and the documented benefits of BP reduction. [19] [20] [21] [22] [23] [24] [25] Regarding antihypertensive therapy, the need for strict BP control throughout each 24-hour period is important, particularly in Asia. 1, 26 This can be facilitated by the use of HBPM (see below for more details), and use of long-acting antihypertensive agents (eg, calcium channel blockers and renin-angiotensin system blockers) is recommended. 1 The benefits of BP lowering in Asian patients may be even greater than those in Western populations because the effect of reducing BP on stroke and heart failure are greater than on coronary artery disease. 27
| CON S EN SUS ON THE PR AC TI C AL US E OF HOME B LOOD PRE SSURE MONITORING
The HOPE Asia Network has produced two key publications on HBPM: detailed consensus recommendations 5 and a practical guidance document (Table 3) . 3 HBPM is an essential component The prevalence of CKD is higher in hypertensive patients than in the general population, and the prevalence of CKD associated with hypertension in Asian populations is increasing Hypertensive patients require more intensive out-of-office BP evaluation and comprehensive cardiovascular evaluation in the presence of CKD Intensive BP control is required for patients with CKD to preserve renal function and to prevent cardiovascular events 6. Atrial fibrillation In hypertensive subjects with atrial fibrillation undergoing anticoagulation, a target systolic BP of <130 mm Hg can be considered to minimize the risk of hemorrhagic stroke 7. Secondary prevention of stroke Stroke is among the leading causes of death and represents a large disease burden in East Asian countries, and it may be related to high sodium intake The relationship between BP reduction and the risk of recurrent stroke is less pronounced than in primary prevention, but BP reduction still substantially benefits patients who survive stroke events Evidence from randomized, controlled trials supports the use of diuretic-based treatment, especially when combined with an angiotensin-converting enzyme inhibitor, for the secondary prevention of stroke and vascular events in poststroke patients High BP and increased BP variability are associated with worse outcomes in patients after stroke. CCBs, with their superior effectiveness for the control of BP variability, can be considered in the management of poststroke hypertension (Continues) 8 . Antihypertensive treatment Strict BP control for the 24-h period is important, especially in Asia A home BP-guided approach is the first practical step for strict BP control on the individual level Use of a long-acting and potent CCB and RAS inhibitor, with or without a diuretic, to control BP is preferable Note: Class I = Evidence and/or general agreement that a given treatment or procedure is beneficial, useful, effective (is recommended/is indicated); Class IIa = Weight of evidence/opinion is in favor of usefulness/efficacy (should be considered); Class IIb = Usefulness/efficacy is less well established by evidence/opinion (may be considered); B = Data derived from a single randomized clinical trial or large nonrandomized studies; C = Consensus of opinion of the experts and/or small studies, retrospective studies, registries. of any hypertension management plan because home BP has been shown to provide better prognostic information than office BP measurements. 9, [28] [29] [30] [31] In addition, high SBP on HBPM significantly increases the risk of major cardiovascular events. 29 HBPM is also an important tool to facilitate the detection of white-coat hypertension and masked hypertension. 32 Identification of white-coat hypertension prevents patients being exposed to unnecessary antihypertensive therapy, while masked hypertension needs to be managed effectively aggressively to reduce cardiovascular risk. 33 In addition, HBPM plays a central role in managing high-risk patients with hypertension who have additional cardiovascular risk factors (eg, diabetes, obesity, CKD or other target organ damage, obstructive sleep apnea, and a previous cardiovascular event). 3, 5 Key HBPM parameters include morning SBP, evening SBP, and the morning-evening difference. 3, 5 These provide physicians with the information and tools necessary to implement HBPM techniques into their clinical practice.
TA B L E 4 Home blood pressure (BP) values (mm Hg) corresponding to office measurements
Effective and widespread use of HBPM using the recommended methods should contribute to improving control of hypertension in Asia. Key practice points for HBPM are summarized in Table 5 .
| CON S EN SUS ON THE PR AC TI C AL US E OF AMBUL ATORY B LOOD PRE SSURE MONITORING
More recently, the HOPE Asia Network has published consensus recommendations for the use of ABPM in Asia (Tables 6-12 ), 4 and the associated practical guidance document is being prepared for journal submission. 2 ABPM is the gold standard method for diagnosing hypertension and monitoring antihypertensive therapy. In clinical practice, it is recommended that ABPM be used in conjunction with HBPM because each provides complementary data. 32, 34, 35 Like HBPM, ABPM is a useful tool for detecting white-coat and masked hypertension. In addition, ABPM is the only method of BP measurement that allows BP to be determined during sleep, calculation of mean 24-hour BP, and assessment of short-term BP variability. Determination of BP variability is important because greater variability in SBP has been shown to be an independent predictor of mortality. 36, 37 Furthermore, ABPM provides good predictive information about the risk and occurrence of target organ damage, and cardiovascular morbidity and mortality. 34, [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] In fact, in patients with hypertension, ABPM measures show better correlation with the cardiovascular event rate than office BP. 38, 39, [56] [57] [58] [59] Therefore, ABPM provides essential information on which to base cardiovascular risk management decisions. Note: Class I = Evidence and/or general agreement that a given treatment or procedure is beneficial, useful, effective (is recommended/is indicated); Class IIa = Weight of evidence/ opinion is in favor of usefulness/efficacy (should be considered); A = Data derived from multiple randomized clinical trials or meta-analyses; B = Data derived from a single randomized clinical trial or large nonrandomized studies; C = Consensus of opinion of the experts and/or small studies, retrospective studies, registries. Note: Class I = Evidence and/or general agreement that a given treatment or procedure is beneficial, useful, effective (is recommended/is indicated); Class IIa = Weight of evidence/ opinion is in favor of usefulness/efficacy (should be considered); A = Data derived from multiple randomized clinical trials or meta-analyses; B = Data derived from a single randomized clinical trial or large nonrandomized studies.
Recommendation

Class of recommendation Level of evidence
TA B L E 11
Consensus on evidence of ambulatory blood pressure parameters and prediction of cardiovascular (CV) outcomes in Asia (HOPE Asia Network) (reproduced, with permission) 4 Note: Class I = Evidence and/or general agreement that a given treatment or procedure is beneficial, useful, effective (is recommended/is indicated); Class IIa = Weight of evidence/ opinion is in favor of usefulness/efficacy (should be considered); A = Data derived from multiple randomized clinical trials or meta-analyses; B = Data derived from a single randomized clinical trial or large nonrandomized studies.
Recommendation
Class of recommendation
TA B L E 1 0
Consensus on assessment and definition of disrupted diurnal blood pressure (BP) rhythm, morning BP surge, and BP variability in Asia (HOPE Asia Network) (reproduced, with permission) 4 Use of ABPM in Asia is important because the prevalence of masked hypertension in the region is high, and Asian characteristics of hypertension include disrupted BP variability, with an increased morning BP surge and nocturnal hypertension. [60] [61] [62] [63] [64] [65] [66] However, the current use of ABPM in the region is variable. (Table 13) .
ABPM also provides good information on control of BP throughout the 24-hour period, and about an individual's BP in their usual daily environment and routine, meaning that any influence of emotional or environmental factors can be detected and managed appropriately. 34, 68 Key practice points for ABPM are summarized in Table 14 .
New information and communication technology-based solutions are being developed that not only automatically monitor BP to prevent the onset of these events. Such an approach is referred to as "anticipation medicine" for zero cardiovascular events. 69
| CON CLUS ION
Based on a growing body of Asia-specific evidence, there are now a number of robust consensus recommendation documents to guide management of hypertension in Asia. [1] [2] [3] [4] [5] 
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